Results 141 to 150 of about 118,981 (359)

Nickel (II) Ions Interaction with Polynucleotides and DNA of Different GC Composition [PDF]

open access: yesarXiv, 2009
The goal of the work was to study the role of GC alternative dimmers in the binding of DNA with Ni (II) ions. The method of ultraviolet difference spectroscopy has been applied to investigate Ni (II) ions interactions with DNA extracted from Clostridium perfringens, Mice liver (C3HA line), Calf thymus, Salmon sperm, Herring sperm, E.coli, Micrococcus ...
arxiv  

Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms

open access: yesInternational Journal of Cancer, Volume 156, Issue 11, Page 2053-2067, 1 June 2025.
Abstract The biology of cancer is characterized by an intricate interplay of cells originating not only from the tumor mass, but also its surrounding environment. Different microbial species have been suggested to be enriched in tumors and the impacts of these on tumor phenotypes is subject to intensive investigation.
Kamil Moskal   +6 more
wiley   +1 more source

Empyema Caused by Clostridium difficile

open access: yesCanadian Journal of Infectious Diseases, 1999
Extraintestinal infections of Clostridium difficile are rare and often associated with underlying disorders. A case of empyema caused by aspiration of C difficile in a patient with carcinoid syndrome and C difficile colitis is described.
Darren A Hudson   +2 more
doaj   +1 more source

The role of hospital environment and the hands of medical staff in the transmission of the Clostridioides (Clostridium) difficile infection

open access: yesMedycyna Pracy, 2019
This paper attempts to determine the role of the hospital environment in the spread of Clostridioides/Clostridium (C.) difficile infections based on a review of studies published in the medical literature and in the light of the authors’ own ...
Monika Kabała   +2 more
doaj   +1 more source

[Infections caused by Clostridium difficile].

open access: yesEnfermedades infecciosas y microbiologia clinica, 2013
The epidemiology of Clostridium difficile infections (CDIs) has dramatically changed over the last decade in both North America and Europe, and it has become more frequent, more severe, more refractory to standard therapy, and more likely to relapse. These changes have been associated with the emergence of a "hypervirulent" strain known as BI/NAP1/027 ...
Rodriguez-Pardo, D   +2 more
openaire   +2 more sources

Antimicrobial Susceptibility Profile of Eggerthella lenta Isolated From Bloodstream and Abdominal Fluid Infections

open access: yesiLABMED, EarlyView.
Antimicrobial susceptibility analysis of clinical Eggerthella lenta isolates. This study reviewed 36 E. lenta isolates from the bloodstream and abdominal fluids (2018–2024). Identification methods included VITEK 2 ANC, MALDI‐TOF, and 16S rRNA sequencing. Antimicrobial susceptibility testing using agar dilution followed CLSI and EUCAST guidelines.
Yuan Gao   +4 more
wiley   +1 more source

Native synthetic microbial communities enhance zha‐chili by boosting the fermentation capacity of indigenous microorganisms

open access: yesiMetaOmics, EarlyView.
Traditional fermented foods in synthetic microbial communities (SynComs). We simulated the production of zha‐chili, a traditional fermented food, in the laboratory, intending to address the following questions: How are SynComs constructed, and what is the effect of inoculation with SynComs on the quality of zha‐chilli? How does inoculation with SynComs
Hongye Shen   +7 more
wiley   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu   +8 more
wiley   +1 more source

Assessing Engraftment Following Fecal Microbiota Transplant [PDF]

open access: yesarXiv
Fecal Microbiota Transplant (FMT) is an FDA approved treatment for recurrent Clostridium difficile infections, and is being explored for other clinical applications, from alleviating digestive and neurological disorders, to priming the microbiome for cancer treatment, and restoring microbiomes impacted by cancer treatment.
arxiv  

Home - About - Disclaimer - Privacy